Văcxin MMRV có kết quả theo dõi dài hạn tốt
TT - Đây là kết quả nghiên cứu của các nhà khoa học thuộc Trung tâm Nghiên cứu văcxin Permanente Kaiser (California, Mỹ).  Một nghiên cứu dài hạn trong 12 năm đánh giá việc tiêm chủng văcxin 4 trong 1 MMRV (sởi - quai bị - rubella - thủy đậu) so với tiêm cùng một ngày hai mũi văcxin khác nhau MMR và thủy đậu (MMR+V) cho thấy cả hai phương pháp đều an toàn và mang lại hiệu quả bảo vệ cho trẻ từ 1-2 tuổi.
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